About T-box transcription factor TBX19
T-box transcription factor TBX19 (TBX19) is a protein
from Homo sapiens identified by UniProt accession
O60806, 448 residues long.
MolForge cross-references it against 0 known binders and
110 disease associations.
Target properties
| Protein name | T-box transcription factor TBX19 |
| UniProt accession | O60806 |
| Gene | TBX19 |
| Organism | Homo sapiens |
| Length | 448 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (110)
Diseases linked to this target (Open Targets).
- Adrenocorticotropic hormone deficiency · score 0.72
- genetic disorder · score 0.41
- lymphedema, hereditary, iii · score 0.27
- neutrophil count · score 0.24
- pituitary stalk interruption syndrome · score 0.13
- testosterone measurement · score 0.09
- neoplasm · score 0.09
- PHF-tau measurement · score 0.06
- familial glucocorticoid deficiency · score 0.06
- obesity due to pro-opiomelanocortin deficiency · score 0.05
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-O60806-F1 | alphafold | PREDICTED | 62.74 | — |
Amino-acid sequence (448 residues)
MAMSELGTRK PSDGTVSHLL NVVESELQAG REKGDPTEKQ LQIILEDAPL WQRFKEVTNE MIVTKNGRRM FPVLKISVTG LDPNAMYSLL LDFVPTDSHR WKYVNGEWVP AGKPEVSSHS CVYIHPDSPN FGAHWMKAPI SFSKVKLTNK LNGGGQIMLN SLHKYEPQVH IVRVGSAHRM VTNCSFPETQ FIAVTAYQNE EITALKIKYN PFAKAFLDAK ERNHLRDVPE AISESQHVTY SHLGGWIFSN PDGVCTAGNS NYQYAAPLPL PAPHTHHGCE HYSGLRGHRQ APYPSAYMHR NHSPSVNLIE SSSNNLQVFS GPDSWTSLSS TPHASILSVP HTNGPINPGP SPYPCLWTIS NGAGGPSGPG PEVHASTPGA FLLGNPAVTS PPSVLSTQAP TSAGVEVLGE PSLTSIAVST WTAVASHPFA GWGGPGAGGH HSPSSLDG
Explore T-box transcription factor TBX19 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets